Form 4 for ICE Intercontinental Exchange
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0000950170-24-015369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | 2024-02-12 | ICE | Foley Douglas | SVP, HR, Administration | A - Grant | $0.00 | +4,309 | 27.8K | +18% | $0 |
| DM | 2024-02-14 | 2024-02-12+ | ICE | Foley Douglas | SVP, HR, Administration | M - OptEx | $41.59 | +12.2K | 25.5K | +92% | +$507.8K |
| D | 2024-02-14 | 2024-02-12 | ICE | Foley Douglas | SVP, HR, Administration | S - Sale+OE | $136.09 | -7,070 | 18.4K | -28% | -$962.2K |
| D | 2024-02-14 | 2024-02-12 | ICE | Foley Douglas | SVP, HR, Administration | F - Tax | $135.46 | -646 | 27.2K | -2% | -$87.5K |
| D | 2024-02-14 | 2024-02-12 | ICE | Foley Douglas | SVP, HR, Administration | A - Grant | $0.00 | +5,324 | 5,324 | New | $0 |
| DM | 2024-02-14 | 2024-02-12+ | ICE | Foley Douglas | SVP, HR, Administration | M - OptEx | $0.00 | -12.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | A | A | 4,309 | $0.00 | 27,832 | D | — | — | (F2) Represents shares of performance based restricted stock units granted to the filing person on February 3, 2023. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2023 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 12, 2024, 1/3 on February 12, 2025 and 1/3 on February 12, 2026). Of the 4,309 shares, 1,435 were issued on February 12, 2024, of which 646 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,874 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. |
| 2 | Common | Common Stock | 2024-02-14 | M | A | 5,140 | $41.59 | 23,523 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-12 | S | D | 7,070 | $136.09 | 18,383 | D | — | — | (F1) The price range for the aggregate amount sold by the direct holder is $136.08 to $136.11. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-02-12 | M | A | 7,070 | $41.59 | 25,453 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-12 | F | D | 646 | $135.46 | 27,186 | D | — | — | (F3) Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. (F4) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. (F5) The common stock number referred in Table I is an aggregate number and represents 21,657 shares of common stock and 5,529 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2024 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting. The satisfaction of the 2022, 2023 and 2024 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025, February 2026 and February 2027, respectively, and will be reported at the time of vesting. |
| 6 | Derivative | Employee Stock Option (right to buy) Holding | 2024-02-12 | A | A | 5,324 | $0.00 | 5,324 | D | $135.46 · — to 2034-02-12 | 5,324 Common Stock | (F7) These options vest in accordance with the following schedule: 33.33% of the options vest on February 12, 2025, 33.33% of the options vest on February 12, 2026 and 33.33% of the options vest on February 12, 2027. |
| 7 | Derivative | Employee Stock Option (right to buy) Holding | 2024-02-12 | M | D | 7,070 | $0.00 | 5,140 | D | $41.59 · — to 2025-01-20 | 7,070 Common Stock | (F6) These options are fully vested. |
| 8 | Derivative | Employee Stock Option (right to buy) Holding | 2024-02-14 | M | D | 5,140 | $0.00 | 0 | D | $41.59 · — to 2025-01-20 | 5,140 Common Stock | (F6) These options are fully vested. |